All In MedTech

Device Trial Radar · NCT02214784

Neurotech Vital Device For The Treatment Of Stress Urinary Incontinence

A Randomised Controlled Double-Blind Clinical Study To Evaluate The Safety And Performance Of Neuromuscular Electrical Stimulation (NMES) With The Neurotech Vital Device For The Treatment Of Stress Urinary Incontinence

Last checked: Nov 20, 2026Latest source record: Feb 5, 2018 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

50

Actual

Start

Dec 2012

Primary completion

Jan 2015

Study completion Jan 2015

Sponsor

Lead sponsor
Atlantic TherapeuticsAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Aug 12, 2014

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Crossover
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
Who can join
Female only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Stress Urinary Incontinence (SUI) is described as an uncontrolled loss of urine which happens when physical activities such as running, jumping and lifting etc are carried out or when increased pressure to the bladder in everyday life is applied by simply sneezing or coughing. There are various treatment options available - surgical operations, pelvic floor exercises/muscle training and electrical stimulation. This study aims to prove that using the Neurotech Vital device for 12 weeks can stimulate the pelvic floor muscles to strengthen and tone them and in doing so improving stress urinary incontinence. We are comparing the Neurotech Vital device with an altered Neurotech Vital device that does not give the same stimulation treatment. There is a 50% chance of you receiving the altered device, if you do, you will be offered the non-altered Neurotech vital device after your first 12 week treatment programme. Both devices are identical in looks, but give different stimulations through the skin contact electrodes.

Conditions

  • Stress Urinary Incontinence

Interventions

  • Active Neurotech VitalDevice

    12 weeks treatment for 30 minutes per day, 5 days out of 7.

  • Modified Neurotech Vital DeviceDevice

    12 weeks treatment for 30 minutes per day for 5 days out of 7.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. All participants taking part in a standardised 1-minute stress testTime frame: 12 weeks

1 more outcomes with a free account

Locations

3 sites in 1 country. Site status is shown where the registry gives one.

  • St Hedwig Krankenhaus

    Berlin, Germany

2 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.